Compare KT & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KT | BIRK |
|---|---|---|
| Founded | 1981 | 1774 |
| Country | South Korea | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 7.0B |
| IPO Year | 2002 | 2023 |
| Metric | KT | BIRK |
|---|---|---|
| Price | $21.81 | $36.21 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 14 |
| Target Price | N/A | ★ $62.69 |
| AVG Volume (30 Days) | 2.1M | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.34% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.71 |
| Revenue Next Year | $1.97 | $14.21 |
| P/E Ratio | ★ $15.73 | $17.48 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.25 | $36.14 |
| 52 Week High | $24.58 | $57.39 |
| Indicator | KT | BIRK |
|---|---|---|
| Relative Strength Index (RSI) | 43.32 | 36.19 |
| Support Level | $21.51 | N/A |
| Resistance Level | $24.58 | $42.19 |
| Average True Range (ATR) | 0.56 | 1.68 |
| MACD | -0.33 | -0.47 |
| Stochastic Oscillator | 13.48 | 7.45 |
KT is South Korea's largest fixed-line telecom operator, with around 11.5 million fixed-line broadband customers and 9.5 million IPTV customers, and is the second-largest wireless operator with 28 million subscribers. Additionally, it has a number of nontelecom businesses, including real estate, payment processing, artificial intelligence, and IDC/cloud services, many of which are the focus of its growth strategy. The company was formed from the previously government-owned, monopoly telecom business and was listed in 1998. After selling its mobile business in 1994 (forming its mobile competitor, SK Telecom), KT created its own mobile operator in 1997.
Birkenstock is a German footwear brand known for comfort-focused, timeless designs, with 76% of 2022 sales coming from its top five iconic models. Products are made in Europe using sustainable, mostly locally sourced materials. The brand combines orthopedic function with everyday style, appealing to a broad audience. The Americas account for 52% of sales, EMEA 37%, with the remainder coming from Asia-Pacific, which has also the higher future growth expectations.